Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $126,094 - $156,759
520 Added 11.95%
4,871 $1.2 Million
Q2 2022

Aug 12, 2022

SELL
$224.73 - $338.64 $453,954 - $684,052
-2,020 Reduced 31.71%
4,351 $1.08 Million
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $338,245 - $446,873
-1,220 Reduced 16.07%
6,371 $2.11 Million
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $18,037 - $22,281
-60 Reduced 0.78%
7,591 $2.73 Million
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $170,604 - $206,910
550 Added 7.75%
7,651 $2.49 Million
Q2 2021

Aug 13, 2021

BUY
$262.71 - $351.17 $740,842 - $990,299
2,820 Added 65.87%
7,101 $2.22 Million
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $208,721 - $259,244
730 Added 20.56%
4,281 $1.36 Million
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $478,572 - $615,980
-1,900 Reduced 34.86%
3,551 $1.15 Million
Q3 2020

Nov 13, 2020

BUY
$255.22 - $317.0 $280,742 - $348,700
1,100 Added 25.28%
5,451 $1.51 Million
Q2 2020

Aug 14, 2020

SELL
$141.4 - $257.09 $28,280 - $51,417
-200 Reduced 4.39%
4,351 $1.05 Million
Q1 2020

May 14, 2020

SELL
$130.51 - $196.01 $429,377 - $644,872
-3,290 Reduced 41.96%
4,551 $661,000
Q4 2019

Feb 14, 2020

SELL
$159.31 - $223.54 $149,751 - $210,127
-940 Reduced 10.7%
7,841 $1.34 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $506,739 - $804,461
2,881 Added 48.83%
8,781 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $652,496 - $740,844
-2,600 Reduced 30.59%
5,900 $1.54 Million
Q1 2019

May 14, 2019

BUY
$276.39 - $362.25 $1.71 Million - $2.25 Million
6,200 Added 269.57%
8,500 $2.43 Million
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $56,216 - $88,850
200 Added 9.52%
2,300 $748,000
Q3 2018

Nov 14, 2018

SELL
$354.53 - $449.75 $70,906 - $89,950
-200 Reduced 8.7%
2,100 $944,000
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $639,561 - $1.03 Million
2,300 New
2,300 $941,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.